DOCTEUR ELISE ARBONA-VIDAL : revenue, balance sheet and financial ratios

DOCTEUR ELISE ARBONA-VIDAL is a French company founded 10 years ago, specialized in the sector Autres activités des médecins spécialistes. Based in TASSIN-LA-DEMI-LUNE (69160), this company of category PME shows in 2024 a revenue of 215 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-09-19

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Synthèse

Santé financière : Saine

Aucun signal de fragilité majeur : rentabilité positive et structure financière équilibrée.

In summary, DOCTEUR ELISE ARBONA-VIDAL combines a growing business with positive profitability. Its financial structure is broadly in line with its sector.

Financial history - DOCTEUR ELISE ARBONA-VIDAL (SIREN 818330987)
Indicator 2024 2023 2021 2020 2019 2018 2017 2016
Revenue 214 743 € 203 485 € 199 267 € 172 897 € 205 795 € 217 616 € 221 456 € 169 135 €
Net income 12 321 € 5 687 € 17 671 € -2 425 € 27 629 € 311 € 11 427 € 21 357 €
EBITDA 14 220 € 8 608 € 22 818 € -1 336 € 35 360 € 4 170 € 16 339 € 27 480 €
Net margin 5.7% 2.8% 8.9% -1.4% 13.4% 0.1% 5.2% 12.6%

Revenue and income statement

In 2024, DOCTEUR ELISE ARBONA-VIDAL achieves revenue of 215 k€. Revenue is growing positively over 8 years (CAGR: +0.9%). Vs 2023: +6%. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 14 k€, representing 6.6% of revenue. Positive scissor effect: EBITDA margin improves by +2.4 pts, sign of improved operational efficiency. This ratio is slightly less favorable than the sector median (18.1%). Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 12 k€, i.e. 5.7% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

214 743 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

214 743 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

14 220 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

12 816 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

12 321 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

6.6%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 19%. This ratio is slightly less favorable than the sector median (17.0%). Financial autonomy (= Equity / Total assets x 100) reaches 15%. This ratio is less favorable than the sector median (58.4%) and warrants attention. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.4 years of cash flow to repay all financial debt. This ratio is more favorable than the sector median (0.4 years). Cash flow represents 7.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This ratio is slightly less favorable than the sector median (14.3%).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

19.45%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

14.91%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

7.2%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.37

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

13.9%

Solvency indicators evolution
DOCTEUR ELISE ARBONA-VIDAL

Sector positioning

Debt ratio
19.45% 2024
Q1: 2.48%
Med: 17.02%
Q3: 59.32%
Average +49 pts over 3 years

In 2024, the debt ratio of DOCTEUR ELISE ARBONA-VIDAL (19.4%) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
14.91% 2024
Q1: 38.0%
Med: 58.39%
Q3: 80.39%
Watch +9 pts over 3 years

In 2024, the financial autonomy of DOCTEUR ELISE ARBONA-VIDAL (14.9%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
0.37 years 2024
Q1: 0.01 years
Med: 0.44 years
Q3: 1.44 years
Good +21 pts over 3 years

In 2024, the repayment capacity of DOCTEUR ELISE ARBONA-VIDAL (0.37) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 10.21. Compared with its sector, this ratio places the company among the best positioned (sector median: 3.6).

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

10.21

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.0

Liquidity indicators evolution
DOCTEUR ELISE ARBONA-VIDAL

Sector positioning

Liquidity ratio
10.21 2024
Q1: 1.61
Med: 3.56
Q3: 9.11
Excellent +19 pts over 3 years

In 2024, the liquidity ratio of DOCTEUR ELISE ARBONA-VIDAL (10.21) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
0.0x 2024
Q1: 0.0x
Med: 0.31x
Q3: 1.75x
Average -40 pts over 3 years

In 2024, the interest coverage of DOCTEUR ELISE ARBONA-VIDAL (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 10 days. Favorable situation: supplier credit is longer than customer credit by 10 days. Overall, WCR represents 20 days of revenue, i.e. 12 k€ to permanently finance. Between 2020 and 2024, WCR worsened by 45 days of revenue, signaling an increased financing need.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

11 725 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

10 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

20 j

WCR and payment terms evolution
DOCTEUR ELISE ARBONA-VIDAL

Positioning of DOCTEUR ELISE ARBONA-VIDAL in its sector

Comparison with sector Autres activités des médecins spécialistes

Valuation estimate

Based on 274 transactions of similar company sales (all years), the value of DOCTEUR ELISE ARBONA-VIDAL is estimated at 62 773 € (range 23 003€ - 127 145€). With an EBITDA of 14 220€, the sector multiple of 3.6x is applied. The price/revenue ratio is 0.43x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
274 transactions
23k€ 62k€ 127k€
62 773 € Range: 23 003€ - 127 145€
Section all-time Aggregated at NAF section level

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
14 220 € × 3.6x
Estimation 51 036 €
20 634€ - 114 407€
Revenue Multiple 30%
214 743 € × 0.43x
Estimation 91 639 €
33 786€ - 153 334€
Net Income Multiple 20%
12 321 € × 4.0x
Estimation 48 820 €
12 756€ - 119 708€
How is this estimate calculated?

This estimate is based on the analysis of 274 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Autres activités des médecins spécialistes)

Compare DOCTEUR ELISE ARBONA-VIDAL with other companies in the same sector:

Voir toutes les statistiques du secteur Autres activités des médecins spécialistes

Top companies in Autres activités des médecins spécialistes

Largest companies by revenue in the sector Autres activités des médecins spécialistes:

Top companies in Rhone

Largest companies by revenue in the department Rhone:

Voir le classement complet du département Rhone

Frequently asked questions about DOCTEUR ELISE ARBONA-VIDAL

What is the revenue of DOCTEUR ELISE ARBONA-VIDAL ?

The revenue of DOCTEUR ELISE ARBONA-VIDAL in 2024 is 215 k€.

Is DOCTEUR ELISE ARBONA-VIDAL profitable?

Yes, DOCTEUR ELISE ARBONA-VIDAL generated a net profit of 12 k€ in 2024.

Where is the headquarters of DOCTEUR ELISE ARBONA-VIDAL ?

The headquarters of DOCTEUR ELISE ARBONA-VIDAL is located in TASSIN-LA-DEMI-LUNE (69160), in the department Rhone.

Where to find the tax return of DOCTEUR ELISE ARBONA-VIDAL ?

The tax return of DOCTEUR ELISE ARBONA-VIDAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does DOCTEUR ELISE ARBONA-VIDAL operate?

DOCTEUR ELISE ARBONA-VIDAL operates in the sector Autres activités des médecins spécialistes (NAF code 86.22C). See the 'Sector positioning' section above to compare the company with its competitors.